1. |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
|
2. |
张振山, 姚天宇, 许迪. 幽门螺旋杆菌抗体、胃蛋白酶原、促胃液素-17与胃癌临床分期的相关性. 医学研究与教育, 2022, 39(6): 29-34.
|
3. |
Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol, 2020, 18(3): 534-542.
|
4. |
王罡强, 袁金秋, 张常华, 等. 代谢综合征及其组分与胃癌发生风险前瞻性队列研究. 热带医学杂志, 2021, 21(9): 1096-1102.
|
5. |
Huang D, Shin WK, De la Torre K, et al. Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study. Gastric Cancer, 2023, 26(4): 481-492.
|
6. |
Li H, Feng Z, He ML. Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells. Theranostics, 2020, 10(16): 7053-7069.
|
7. |
Touvier M, Fassier P, His M, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr, 2015, 114(3): 347-357.
|
8. |
周星辰, 张惟纲, 赵昆, 等. 结直肠癌胆固醇代谢及相关治疗研究进展. 中华肿瘤防治杂志, 2023, 30(8): 497-502.
|
9. |
Song YM, Sung J, Kim JS. Which cholesterol level is related to the lowest mortality in a population with low mean cholesterol level: a 6.4-year follow-up study of 482 472 Korean men. Am J Epidemiol, 2000, 151(8): 739-747.
|
10. |
Pih GY, Gong EJ, Choi JY, et al. Associations of serum lipid level with gastric cancer risk, pathology, and prognosis. Cancer Res Treat, 2021, 53(2): 445-456.
|
11. |
Lindkvist B, Almquist M, Bjørge T, et al. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer Causes Control, 2013, 24(1): 107-116.
|
12. |
Gong EJ, Ahn JY, Jung HY, et al. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol, 2014, 29(2): 301-309.
|
13. |
Lim JH, Shin CM, Han K, et al. Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women. Gastric Cancer, 2022, 25(1): 11-21.
|
14. |
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, 372: n71.
|
15. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
16. |
Peters JL, Sutton AJ, Jones DR, et al. Comparison of two methods to detect publication bias in meta-analysis. JAMA, 2006, 295(6): 676-680.
|
17. |
van Enst WA, Ochodo E, Scholten RJ, et al. Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study. BMC Med Res Methodol, 2014, 14: 70.
|
18. |
Törnberg SA, Carstensen JM, Holm LE. Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein. Acta Oncol, 1988, 27(1): 39-42.
|
19. |
Eichholzer M, Stähelin HB, Gutzwiller F, et al. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am J Clin Nutr, 2000, 71(2): 569-574.
|
20. |
Asano K, Kubo M, Yonemoto K, et al. Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. Int J Cancer, 2008, 122(4): 909-914.
|
21. |
Iso H, Ikeda A, Inoue M, et al. Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer, 2009, 125(11): 2679-2686.
|
22. |
Ahn J, Lim U, Weinstein SJ, et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev, 2009, 18(11): 2814-2821.
|
23. |
Kitahara CM, Berrington de González A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol, 2011, 29(12): 1592-1598.
|
24. |
Kang R, Li P, Wang T, et al. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population. Sci Rep, 2016, 6: 19930.
|
25. |
Trichopoulou A, Lagiou P, Kuper H, et al. Cancer and mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev, 2000, 9(9): 869-873.
|
26. |
Hajjar M, Rezazadeh A. Recommended food score and healthy nordic food index in cancer: a systematic review. Nutr Cancer, 2021, 73(3): 369-375.
|
27. |
Ur Rahman MS, Cao J. Estrogen receptors in gastric cancer: advances and perspectives. World J Gastroenterol, 2016, 22(8): 2475-2482.
|
28. |
Abdalkareem Jasim S, Kzar HH, Haider Hamad M, et al. The emerging role of 27-hydroxycholesterol in cancer development and progression: an update. Int Immunopharmacol, 2022, 110: 109074.
|
29. |
Yamauchi Y, Rogers MA. Sterol metabolism and transport in atherosclerosis and cancer. Front Endocrinol (Lausanne), 2018, 9: 509.
|
30. |
Calleros L, Lasa M, Toro MJ, et al. Low cell cholesterol levels increase NFkappaB activity through a p38 MAPK-dependent mechanism. Cell Signal, 2006, 18(12): 2292-2301.
|
31. |
Radišauskas R, Kuzmickienė I, Milinavičienė E, et al. Hypertension, serum lipids and cancer risk: a review of epidemiological evidence. Medicina (Kaunas), 2016, 52(2): 89-98.
|
32. |
Murai T. Cholesterol lowering: role in cancer prevention and treatment. Biol Chem, 2015, 396(1): 1-11.
|
33. |
Ravnskov U, McCully KS, Rosch PJ. The statin-low cholesterol-cancer conundrum. QJM, 2012, 105(4): 383-388.
|
34. |
Strohmaier S, Edlinger M, Manjer J, et al. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can). PLoS One, 2013, 8(1): e54242.
|
35. |
Huxley R, Lewington S, Clarke R. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Semin Vasc Med, 2002, 2(3): 315-323.
|
36. |
Toner CD, Davis CD, Milner JA. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc, 2010, 110(10): 1492-1500.
|
37. |
Ma X, Bi E, Lu Y, et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab, 2019, 30(1): 143-156.
|
38. |
King RJ, Singh PK, Mehla K. The cholesterol pathway: impact on immunity and cancer. Trends Immunol, 2022, 43(1): 78-92.
|